Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. T-bet in disease· 2011 · 235 citations
2. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.· 1993 · 386 citations
3. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo· 2006 · 46 citations
4. A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy· 2014 · 314 citations
5. T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition· 2017 · 1,649 citations